Insights on Surya namaskar from its origin to application towards health.

Suryanamaskar is considered a part of modern-day yogic practices though it was neither considered an asana nor a part of traditional Yoga. Practicing Suryanamaskar before beginning routine activities vitalizes the practitioner and gives a completely energized day. Starting from the Raja of Aundh who first introduced surya namaskar, there is a line of eminent people who popularized this dynamic group of asanas including T Krishnamacharya, Swami Sivananda, Swami Satyananda from Bihar school of Yoga, so on and so forth. Their contributions resulted in this excellent series of Asanas being introduced to the practitioners. Such a miraculous group of postures also involves dynamic breathing patterns at each posture and gives a form of complete practice involving asanas and pranayama. There are a total of 12 postures in Suryanamaskar practice and 24 steps in one round. This is in the form of salutation to the "Sun" along with chanting the twelve names of the sun god. In this review, we accentuate the importance of Suryanamaskar highlighting its effects on physical, psychological and physiological aspects of the body based on published research. In addition, the usefulness of surya namaskar as one complete sadhana for the whole body is emphasized.

Clinico-pathological correlations of fatty acid synthase expression in retinoblastoma: an Indian cohort study.

Retinoblastoma (RB), the most common intra-ocular malignancy in children under 5 years of age, has an estimated incidence of about 2000 a year in India, where most cases are in advanced stage at the time of diagnosis. Newer therapeutic approaches would reduce the morbidity of chemotherapy in children with RB. Fatty Acid Synthase (FASN), a lipogenic multi-enzyme complex, is minimally expressed in normal human tissues and over expressed in many cancers, making it an attractive target for cancer therapy. We analyzed RB tissues for FASN protein expression by immunohistochemistry, western blot, and ELISA, and FASN mRNA expression by RT-PCR. FASN expression was correlated with the clinico-pathological characteristics of the tumors. FASN immunostaining was positive in all the 44 RB tissues analyzed (100%). However, FASN expression was heterogeneous within the tumor samples. Tumors with invasion of choroid, optic nerve, orbit and/or retinal pigment epithelium showed significantly higher FASN immunoreactivity than the tumors without invasion (P<0.05), supported by western analysis (P<0.05). FASN expression was significantly high in poorly differentiated retinoblastomas (P<0.05). FASN protein and FASN mRNA estimated by ELISA and RT-PCR respectively showed multi-fold expression over the non-neoplastic muller glial cells that varied quantitatively between tumor tissues. FASN mRNA over-expression was substantially lower than the corresponding FASN protein expression values. The present study reports (i) markedly high expression of FASN protein in poorly differentiated and in invasive retinoblastomas, and (ii) multi-fold over-expression of FASN mRNA and protein in RB tissues, although at varying levels, indicating FASN to be a potential therapeutic target in retinoblastoma management.

Evaluation of suitable solvents for testing the anti-proliferative activity of triclosan - a hydrophobic drug in cell culture.

Triclosan, a broad spectrum antibiotic is currently being evaluated for its anti-cancer property. Though several solvents are available to dissolve lipophilic (hydrophobic) drugs, solubility and toxicity aspects pose a challenge, when combined with the cell culture medium. In this paper, we present a simple approach based on physico-chemical and biologic criteria to choose a suitable solubilizing agent to study the anti-proliferative property of triclosan in breast cancer cell line MCF-7. Triclosan was dissolved in five different solvents viz. DMSO, absolute ethanol, 1 N NaOH, 55% polyethylene glycol + 45% ethanol mixture (PEM) and acetone and diluted with the culture medium (1 mg/ml). Although triclosan dissolved completely in all five solvents, on dilution with culture medium, turbidity was observed in DMSO, 1 N NaOH and ethanol. Cell viability was 95.23% in 10 microl of acetone, when compared with 49.45% at the same volume of PEM. This non-toxic nature of acetone was supported by DNA fragmentation analysis and phase contrast microscopy. A significant decrease in cancer cell proliferation at 100 microg/ml of acetone-solubilized triclosan, compared with 100 microg/ml of PEM-solubilized triclosan (p<0.05) indicated stronger anti-proliferative effect and greater drug-sensitivity of triclosan when solubilized in acetone. Results showed that acetone-solubilized triclosan was suitable for anti-cancer investigations in cultured MCF-7 cells.

Chemical inhibition of fatty acid synthase: molecular docking analysis and biochemical validation in ocular cancer cells.

Fatty acid biosynthesis is an attractive target for anti-cancer therapeutics. The ocular cancer, retinoblastoma cells were treated with fatty acid synthase (FASN) enzyme inhibitors: cerulenin, triclosan and orlistat. The IC(50) and dose-dependent sensitivity of cancer cells to FASN inhibitors decrease in biologic enzyme activity, and cell morphology alterations were analysed. Molecular interactions of enzyme-inhibitor complexes were studied by molecular modelling and docking simulations. The crystal structures of ketoacyl synthase (PDB ID:3HHD) (cerulenin) and thioesterase (PDB ID:2PX6) (orlistat) domains of human FASN were utilized for docking, while for the non-crystallised human FASN enoyl reductase domain (triclosan), homology model was built and used for docking. All three inhibitors showed significant binding energy indicating stable complex formation with their respective FASN subunits. The predicted Ki value of the FASN inhibitors corroborated well with their corresponding anti-cancer effects.

Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.

PURPOSE: Retinoblastoma (RB) is the most common primary intraocular malignancy of infancy and childhood, where tumor invasion into the choroid, optic nerve, and/or orbit are risk factors for metastasis. Here we have correlated oxidative stress with the clinicopathologic characteristics of retinoblastoma. METHODS: Tumor samples were processed for histopathologic examination. Malondialdehyde, a biomarker of oxidative stress, was immunohistochemically analyzed in 34 archival retinoblastoma tumor specimens, which included 17 tumors that did not have any invasion of the choroid, optic nerve, and/or orbit, and another 17 tumors that had some form of invasion of the choroid, optic nerve, and/or orbit. Lipid peroxidation levels were biochemically measured in another cohort of retinoblastoma tissue samples (n = 16), and correlated clinicopathologically. RESULTS: Malondialdehyde immunostaining was positive in all 34/34 (100%) tumors, and their corresponding clinicopathologic features were recorded. Malondialdehyde levels were significantly higher in tumors with invasion of the choroid, optic nerve, and orbit, when compared with tumors with no invasion (p < 0.05). No significant correlation was noted between malondialdehyde immunoreactivity and the differentiation/laterality of the tumors. Lipid peroxidation levels increased significantly in tumors with invasion of the choroid, optic nerve, and orbit than in tumors without invasion (p < 0.05). CONCLUSION: RB with invasion of the choroid, optic nerve, and/or orbit strongly correlates with increased oxidative stress.